Geratherm Medical (0EL9) Price & Analysis

0 Followers

0EL9 Stock Chart & Stats

€2.84

€0.08(2.35%)

At close: Jan 06 4:00 PM EST

€2.84

€0.08(2.35%)

Day’s Range― - ―

52-Week Range€2.25 - €4.45

Previous CloseN/A

Volume52.00

Average Volume (3M)4.00

Market Cap

€11.82M

Enterprise Value€7.55M

Total Cash (Recent Filing)€8.81M

Total Debt (Recent Filing)€2.19M

Price to Earnings (P/E)―

Beta0.38

Next Earnings

Apr 27, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.14

Shares Outstanding5,444,998

10 Day Avg. Volume0

30 Day Avg. Volume4

Financial Highlights & Ratios

PEG Ratio0.09

Price to Book (P/B)0.80

Price to Sales (P/S)1.05

P/FCF Ratio12.78

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.02

Revenue Forecast (FY)€15.00M

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a substantial equity base give Geratherm financial flexibility to fund operations and withstand periods of weaker demand. This conservative capital structure also reduces financing pressure and preserves room for investment or strategic actions over the next several quarters.

Positive Cash GenerationPositive operating and free cash flow show that Geratherm's medical-device sales are still converting into cash despite recent earnings weakness. Ongoing cash generation can support working capital, product commercialization, and business continuity without relying entirely on external funding.

Strong Gross MarginA gross margin near 67% indicates meaningful value retained after direct product costs, creating potential capacity to absorb selling expenses and support research, marketing, or distribution. If maintained, this provides an important foundation for restoring operating profitability as sales stabilize.

Bears Say

Sharp Revenue DeteriorationThe sharp decline in reported revenue signals weakened demand or execution across the product portfolio and makes the near-term earnings base less dependable. Lower scale can also reduce operating leverage, limiting the company's ability to convert its strong gross margin into sustainable profits.

Return To Loss-making OperationsThe return to negative net and operating margins shows that Geratherm is not currently covering its full operating cost base from revenue. Continued losses could erode retained capital and restrict investment capacity, while also making future performance more dependent on a successful operational recovery.

Weakening Free Cash FlowAlthough cash flow remains positive, the substantial year-over-year decline reduces confidence in the durability of internal funding. Weaker free cash flow may constrain product investment and shareholder distributions if the deterioration persists alongside falling revenue and negative operating profitability.

0EL9 FAQ

What was Geratherm Medical AG’s price range in the past 12 months?

Geratherm Medical AG lowest share price was €2.25 and its highest was €4.45 in the past 12 months.

What is Geratherm Medical AG’s market cap?

Geratherm Medical AG’s market cap is €11.82M.

When is Geratherm Medical AG’s upcoming earnings report date?

Geratherm Medical AG’s upcoming earnings report date is Apr 27, 2027 which is in 186 days.

How were Geratherm Medical AG’s earnings last quarter?

Geratherm Medical AG released its earnings results on Aug 27, 2026. The company reported -€0.08 earnings per share for the quarter.

Is Geratherm Medical AG overvalued?

According to Wall Street analysts Geratherm Medical AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Geratherm Medical AG pay dividends?

Geratherm Medical AG does not currently pay dividends.

What is Geratherm Medical AG’s EPS estimate?

Geratherm Medical AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Geratherm Medical AG have?

Geratherm Medical AG has 5,444,998 shares outstanding.

What happened to Geratherm Medical AG’s price movement after its last earnings report?

Geratherm Medical AG reported an EPS of -€0.08 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Geratherm Medical AG?

Currently, no hedge funds are holding shares in GB:0EL9

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Geratherm Medical Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

-4.38%

Trailing 12-Months

Asset Growth

-7.22%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Geratherm Medical AG

Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range of items including clinical thermometers, blood pressure monitors, and various self-test diagnostic products designed for women, such as pregnancy tests, chlamydia screens, urinary tract infection indicators, diverse ovulation solutions, and pH tests. Its Respiratory segment is dedicated to the development and production of equipment primarily for diagnosing pulmonary and cardiopulmonary function. Under the LMT brand, the Medical Warming Systems division manufactures MRI-compatible incubators for premature and newborn infants. The Cardio/Stroke segment provides analytical products aimed at assessing stroke risk by detecting atrial fibrillation. The company markets its healthcare solutions via pharmacies, hospitals, and clinics, and successfully exports its merchandise to approximately 60 nations worldwide. Established in 1990, Geratherm Medical AG's headquarters are situated in Geschwenda, Germany.